Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Proof-of-concept Study With NVD-003, an Autologous Osteogenic Bone Graft, in the Treatment of Congenital Pseudarthrosis of the Tibia in Pediatric Patients.

NCT05693558 is registered in ClinicalTrials.gov with Novadip Biosciences as lead sponsor.

NCT NCT05693558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05693558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Proof-of-concept Study With NVD-003, an Autologous Osteogenic Bone Graft, in the Treatment of Congenital Pseudarthrosis of the Tibia in Pediatric Patients.
Lead sponsor
Novadip Biosciences
Phase
Phase 1
Overall status
Unknown status
Start date
November 24, 2022
Completion date
January 31, 2026
Enrollment
4 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

congenital pseudarthrosis of tibia